James Clayton, Director of Laboratory Sciences at PDI09.04.20
As the COVID-19 pandemic continues to strain our communities, our economies and our healthcare systems, our understanding of how the virus can be controlled is paramount. The early scientific consensus was that the virus would be sensitive to disinfectants due in large part to its lipid envelope [1]. This protective layer of fat breaks down relatively easily when exposed to disinfectants, inactivating the virus. Early data supported this hypothesis—but much more research was needed to reliably inform our infection control practices. We need to arm both our healthcare professionals and community with disinfectants that we know are effective.
Emerging Pathogens
When a new pathogen emerges, it takes time to get the organism in the hands of researchers who can safely handle and study its behavior in a controlled manner. Typically, the Centers for Disease Control and Prevention (CDC) or the National Institute of Allergy and Infectious Diseases (NIAID) catalogs the organism and prepares it for dissemination to a specific set of scientists. In the case of SARS-CoV-2, the virus was handled by the Biodefense and Emerging Infec
Emerging Pathogens
When a new pathogen emerges, it takes time to get the organism in the hands of researchers who can safely handle and study its behavior in a controlled manner. Typically, the Centers for Disease Control and Prevention (CDC) or the National Institute of Allergy and Infectious Diseases (NIAID) catalogs the organism and prepares it for dissemination to a specific set of scientists. In the case of SARS-CoV-2, the virus was handled by the Biodefense and Emerging Infec
Continue reading this story and get 24/7 access to Nonwovens Industry for FREE
FREE SUBSCRIPTION
